Caribou Biosciences, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $11.2 | $10.0 | $34.5 | $13.9 | $9.6 |
| Operating income | -$148.3 | -$166.6 | -$116.1 | -$106.4 | -$67.0 |
| Net income | -$148.1 | -$149.1 | -$102.1 | -$99.4 | -$66.9 |
| Cash Flow Statement | |||||
| Free cash flow | -$112.4 | -$143.1 | -$104.9 | -$97.4 | -$34.6 |
Shares outstanding 99.2M · Free float 87.7%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.